JP2015509098A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015509098A5 JP2015509098A5 JP2014552489A JP2014552489A JP2015509098A5 JP 2015509098 A5 JP2015509098 A5 JP 2015509098A5 JP 2014552489 A JP2014552489 A JP 2014552489A JP 2014552489 A JP2014552489 A JP 2014552489A JP 2015509098 A5 JP2015509098 A5 JP 2015509098A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- compound
- groups
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- VIUASOMYKUSISM-CALDLXRSSA-N CC1C=CC(Cl)=NC1N([C@@H](CC1)C(N([C@@H](C(NC(C2)CC2(F)F)=O)c2ccccc2Cl)c2cccc(F)c2)=O)C1=O Chemical compound CC1C=CC(Cl)=NC1N([C@@H](CC1)C(N([C@@H](C(NC(C2)CC2(F)F)=O)c2ccccc2Cl)c2cccc(F)c2)=O)C1=O VIUASOMYKUSISM-CALDLXRSSA-N 0.000 description 1
- OHHZBBAYBXOBQZ-OZXSUGGESA-N Cc1c([C@@H](C(NC(C2)CC2(F)F)=O)N(C([C@H](CCC2=O)N2c2cc(Cl)ccn2)=O)c2cccc(F)c2)cccc1 Chemical compound Cc1c([C@@H](C(NC(C2)CC2(F)F)=O)N(C([C@H](CCC2=O)N2c2cc(Cl)ccn2)=O)c2cccc(F)c2)cccc1 OHHZBBAYBXOBQZ-OZXSUGGESA-N 0.000 description 1
- WHTZBGLMWBVRDT-BBQAJUCSSA-N O=C(C(c(cccc1)c1Cl)N(C([C@H](COCC1=O)N1c1ncccn1)=O)c1cccc(F)c1)NC(C1)CC1(F)F Chemical compound O=C(C(c(cccc1)c1Cl)N(C([C@H](COCC1=O)N1c1ncccn1)=O)c1cccc(F)c1)NC(C1)CC1(F)F WHTZBGLMWBVRDT-BBQAJUCSSA-N 0.000 description 1
- MUZBUSFCVMZIKR-OZXSUGGESA-N O=C([C@H](CCC1=O)N1c(cc1)ncc1F)N([C@@H](c(cccc1)c1[I](C1)[N]11C(C2)CC2(F)F)C1=O)c1cccc(F)c1 Chemical compound O=C([C@H](CCC1=O)N1c(cc1)ncc1F)N([C@@H](c(cccc1)c1[I](C1)[N]11C(C2)CC2(F)F)C1=O)c1cccc(F)c1 MUZBUSFCVMZIKR-OZXSUGGESA-N 0.000 description 1
- SPJLJXVNZFUXPY-IGKIAQTJSA-N O=C([C@H](CCC1=O)N1c1ncc(C(F)(F)F)cc1)N([C@@H](c(cccc1)c1[Cl-][NH+]1C(CCF)CCF)C1=O)c1cccc(F)c1 Chemical compound O=C([C@H](CCC1=O)N1c1ncc(C(F)(F)F)cc1)N([C@@H](c(cccc1)c1[Cl-][NH+]1C(CCF)CCF)C1=O)c1cccc(F)c1 SPJLJXVNZFUXPY-IGKIAQTJSA-N 0.000 description 1
- JADDQFOQXHJSMC-KCZHJVNMSA-N [O-][N+](CCC1)([C@@H]1C(N([C@@H](C(NC(C1)CC1(F)F)=O)c(cccc1)c1Cl)c1cccc(F)c1)=O)c1nccc(Cl)c1 Chemical compound [O-][N+](CCC1)([C@@H]1C(N([C@@H](C(NC(C1)CC1(F)F)=O)c(cccc1)c1Cl)c1cccc(F)c1)=O)c1nccc(Cl)c1 JADDQFOQXHJSMC-KCZHJVNMSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012070601 | 2012-01-19 | ||
| CNPCT/CN2012/070601 | 2012-01-19 | ||
| PCT/CN2013/000068 WO2013107291A1 (en) | 2012-01-19 | 2013-01-21 | Therapeutically active compounds and their methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017036691A Division JP2017101067A (ja) | 2012-01-19 | 2017-02-28 | 治療上活性な化合物およびそれらの使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015509098A JP2015509098A (ja) | 2015-03-26 |
| JP2015509098A5 true JP2015509098A5 (enExample) | 2016-02-25 |
| JP6313714B2 JP6313714B2 (ja) | 2018-04-18 |
Family
ID=48797706
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014552489A Active JP6313714B2 (ja) | 2012-01-19 | 2013-01-21 | 治療上活性な化合物およびそれらの使用方法 |
| JP2017036691A Withdrawn JP2017101067A (ja) | 2012-01-19 | 2017-02-28 | 治療上活性な化合物およびそれらの使用方法 |
| JP2018207185A Active JP6805220B2 (ja) | 2012-01-19 | 2018-11-02 | 治療上活性な化合物およびそれらの使用方法 |
| JP2020198026A Withdrawn JP2021038263A (ja) | 2012-01-19 | 2020-11-30 | 治療上活性な化合物およびそれらの使用方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017036691A Withdrawn JP2017101067A (ja) | 2012-01-19 | 2017-02-28 | 治療上活性な化合物およびそれらの使用方法 |
| JP2018207185A Active JP6805220B2 (ja) | 2012-01-19 | 2018-11-02 | 治療上活性な化合物およびそれらの使用方法 |
| JP2020198026A Withdrawn JP2021038263A (ja) | 2012-01-19 | 2020-11-30 | 治療上活性な化合物およびそれらの使用方法 |
Country Status (43)
Families Citing this family (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120121515A1 (en) | 2009-03-13 | 2012-05-17 | Lenny Dang | Methods and compositions for cell-proliferation-related disorders |
| TWI598337B (zh) | 2009-06-29 | 2017-09-11 | 阿吉歐斯製藥公司 | 治療化合物及組成物 |
| WO2011050210A1 (en) | 2009-10-21 | 2011-04-28 | Agios Pharmaceuticals, Inc. | Methods and compositions for cell-proliferation-related disorders |
| SMT202400081T1 (it) | 2011-05-03 | 2024-03-13 | Agios Pharmaceuticals Inc | Attivatori della piruvato chinasi per uso in terapia |
| CN102827170A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
| CN102827073A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
| PE20142098A1 (es) | 2012-01-06 | 2015-01-08 | Agios Pharmaceuticals Inc | Compuestos terapeuticamente activos y sus metodos de uso |
| US9474779B2 (en) | 2012-01-19 | 2016-10-25 | Agios Pharmaceuticals, Inc. | Therapeutically active compositions and their methods of use |
| US20150087600A1 (en) * | 2012-01-19 | 2015-03-26 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
| EP2906212A4 (en) | 2012-10-15 | 2016-06-08 | Agios Pharmaceuticals Inc | THERAPEUTIC COMPOUNDS AND COMPOSITIONS |
| WO2015003360A2 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| CN105593215B (zh) | 2013-07-11 | 2019-01-15 | 安吉奥斯医药品有限公司 | 用于治疗癌症的作为idh2突变体抑制剂的2,4-或4,6-二氨基嘧啶化合物 |
| AU2014287122B9 (en) | 2013-07-11 | 2018-11-01 | Les Laboratoires Servier | N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer |
| WO2015003355A2 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| WO2015010297A1 (en) * | 2013-07-25 | 2015-01-29 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| CN103694142A (zh) * | 2013-11-28 | 2014-04-02 | 浙江科技学院 | 4-N-Boc-氨基环己酮的制备方法 |
| WO2015127172A1 (en) * | 2014-02-20 | 2015-08-27 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| WO2015127173A1 (en) * | 2014-02-20 | 2015-08-27 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
| NZ723859A (en) | 2014-03-14 | 2023-01-27 | Servier Lab | Pharmaceutical compositions of therapeutically active compounds and their uses |
| MA39725B1 (fr) * | 2014-03-14 | 2021-09-30 | Les Laboratoires Servier Sas | Compositions pharmaceutiques de composés thérapeutiquement actifs |
| CR20170077A (es) | 2014-08-04 | 2017-06-26 | Nuevolution As | Derivados de heterociclilo opcionalmente condensados de pirimidina útiles para el tratamiento de enfermedades inflamatorias, metabólicas, oncológicas y autoinmunitarias |
| BR112017006425B8 (pt) | 2014-10-01 | 2023-05-16 | Daiichi Sankyo Co Ltd | Compostos derivados de isoxazol, seus usos, inibidores de isocitrato desidrogenase 1 mutante e da produção de d-2 hidroxiglutamato, agente antitumoral e composição farmacêutica compreendendo os mesmos |
| CA2989111C (en) | 2015-06-11 | 2023-10-03 | Agios Pharmaceuticals, Inc. | Methods of using pyruvate kinase activators |
| DE102015011861B4 (de) | 2015-09-10 | 2018-03-01 | Rudolf Schindler | Neue cyclische Carboxamide als NMDA NR2B Rezeptor Inhibitoren |
| FI3362065T3 (fi) | 2015-10-15 | 2024-06-19 | Servier Lab | Ivosidenibiä, sytarabiinia ja daunorubisiinia tai idarubisiinia käsittävä yhdistelmähoito akuutin myelooisen leukemian hoitamiseksi |
| KR102699521B1 (ko) * | 2015-10-15 | 2024-08-26 | 르 라보레또레 쎄르비에르 | 악성 종양의 치료를 위한 조합물 요법 |
| EA039805B1 (ru) * | 2015-11-13 | 2022-03-15 | Аджиос Фармасьютикалз, Инк. | Комбинированная терапия для лечения злокачественных опухолей |
| ES2905915T3 (es) * | 2015-12-04 | 2022-04-12 | Servier Lab | Procedimientos de tratamiento de neoplasias malignas |
| WO2017140758A1 (en) | 2016-02-19 | 2017-08-24 | Debiopharm International S.A. | Derivatives of 2-amino-4-(2-oxazolidinon-3-yl)-pyrimidine fused with a five-membered heteroaromatic ring in 5,6-position which are useful for the treatment of various cancers |
| MA43640A (fr) * | 2016-02-26 | 2018-11-28 | Agios Pharmaceuticals Inc | Inhibiteurs de idh1 pour le traitement de cancers hématologiques et de tumeurs solides |
| ES2842448T3 (es) | 2016-03-22 | 2021-07-14 | Lianyungang Runzhong Pharmaceutical Co Ltd | Compuesto de sultama y método de aplicación del mismo |
| WO2018010142A1 (en) | 2016-07-14 | 2018-01-18 | Shanghai Meton Pharmaceutical Co., Ltd | Iso-citrate dehydrogenase (idh) inhibitor |
| JP6832430B2 (ja) | 2016-08-31 | 2021-02-24 | アジオス ファーマシューティカルズ， インコーポレイテッド | 細胞代謝過程の阻害剤 |
| US12064436B2 (en) | 2017-06-12 | 2024-08-20 | Servier Pharmaceuticals Llc | Methods of treating brain tumors using combination therapy |
| CA3067035A1 (en) * | 2017-06-12 | 2018-12-20 | Agios Pharmaceuticals, Inc. | Methods of treating brain tumors using combination therapy |
| KR102707847B1 (ko) * | 2017-09-22 | 2024-09-23 | 치아타이 티안큉 파마수티컬 그룹 주식회사 | 결정형 설파마이드 화합물 |
| US11066390B2 (en) * | 2017-11-27 | 2021-07-20 | Assia Chemical Industries Ltd. | Solid state forms of Ivosidenib |
| WO2019161383A1 (en) * | 2018-02-19 | 2019-08-22 | The Regents Of The University Of Colorado, A Body Corporate | Oxopiperidine quantitation by mass spectrometry |
| US11013733B2 (en) | 2018-05-16 | 2021-05-25 | Forma Therapeutics, Inc. | Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1) |
| US11311527B2 (en) | 2018-05-16 | 2022-04-26 | Forma Therapeutics, Inc. | Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1) |
| WO2019222551A1 (en) | 2018-05-16 | 2019-11-21 | Forma Therapeutics, Inc. | Solid forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile |
| US11013734B2 (en) | 2018-05-16 | 2021-05-25 | Forma Therapeutics, Inc. | Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation |
| US20210196701A1 (en) | 2018-05-16 | 2021-07-01 | Forma Therapeutics, Inc. | Inhibiting mutant idh-1 |
| US10980788B2 (en) | 2018-06-08 | 2021-04-20 | Agios Pharmaceuticals, Inc. | Therapy for treating malignancies |
| EA202190217A1 (ru) | 2018-07-06 | 2021-04-16 | Аджиос Фармасьютикалз, Инк. | Формы ивосидениба и фармацевтические композиции |
| CA3121202A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| CN109535025B (zh) * | 2018-12-18 | 2022-09-09 | 尚科生物医药（上海）有限公司 | 一种艾伏尼布中间体3,3-二氟环丁胺盐酸盐的制备方法 |
| WO2020127887A1 (en) | 2018-12-21 | 2020-06-25 | Sandoz Ag | Process for the preparation of an intermediate product of ivosidenib |
| AU2020327013B2 (en) | 2019-08-08 | 2026-03-26 | Les Laboratoires Servier | A method for preparing Ivosidenib and an intermediate thereof |
| WO2021028791A1 (en) * | 2019-08-09 | 2021-02-18 | Alembic Pharmaceuticals Limited | An improved process of preparation of ivosidenib |
| TW202120486A (zh) * | 2019-08-09 | 2021-06-01 | 英商阿帝歐斯製藥有限公司 | 新穎化合物 |
| US12358886B2 (en) | 2019-08-09 | 2025-07-15 | Artios Pharma Limited | Heterocyclic compounds for use in the treatment of cancer |
| US12168005B2 (en) | 2019-10-07 | 2024-12-17 | University Hospitals Cleveland Medical Center | Methods for treating wild type isocitrate dehydrogenase 1 cancers |
| WO2021079380A1 (en) * | 2019-10-23 | 2021-04-29 | Msn Laboratories Private Limited, R&D Center | Improved process for the preparation of (2s)-n-{(1s)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)-amino]-2-oxoethyl}-1-(4-cyanopyridin-2-yl)-n-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide |
| TWI873212B (zh) * | 2019-10-29 | 2025-02-21 | 大陸商上海翰森生物醫藥科技有限公司 | 四員環類衍生物調節劑、其製備方法和應用 |
| MX2022007265A (es) | 2019-12-20 | 2022-09-09 | Nuevolution As | Compuestos activos frente a receptores nucleares. |
| UY38994A (es) | 2019-12-20 | 2021-07-30 | Nuevolution As | Compuestos activos frente a receptores nucleares |
| WO2021198956A1 (en) | 2020-03-31 | 2021-10-07 | Nuevolution A/S | Compounds active towards nuclear receptors |
| AU2021245397A1 (en) | 2020-03-31 | 2022-10-20 | Nuevolution A/S | Compounds active towards nuclear receptors |
| CN111349081B (zh) * | 2020-04-28 | 2021-01-15 | 宁波大学科学技术学院 | 一种Ivosidenib及其中间体的手性合成方法 |
| EP4186525A4 (en) | 2020-07-21 | 2024-04-03 | Daiichi Sankyo Company, Limited | COMBINATION OF TEMOZOLOMIDE AND INHIBITOR OF THE MUTANT IDH1 ENZYME |
| CN116332905B (zh) * | 2021-12-23 | 2025-07-08 | 上海翊石医药科技有限公司 | (s)-n-苯基-1-(吡啶-2-基)吡咯烷-2-甲酰胺衍生物 |
| EP4455129A4 (en) * | 2021-12-30 | 2025-05-07 | Shanghai Apeiron Therapeutics Company Limited | Dna polymerase theta inhibitor and use thereof |
| AR133410A1 (es) | 2023-08-01 | 2025-09-24 | Servier Lab | Cocristal de un inhibidor de idh1, proceso de preparación del mismo, composiciones farmacéuticas del mismo, y métodos de tratamiento que implican el mismo |
| CN117776955A (zh) * | 2023-12-27 | 2024-03-29 | 苏州莱安医药化学技术有限公司 | 一种艾伏尼布及其中间体的合成方法 |
Family Cites Families (162)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2390529A (en) | 1942-02-03 | 1945-12-11 | Ernst A H Friedheim | Hydrazino-1,3,5-triazino derivatives of substituted phenylarsenic compounds |
| NL125847C (enExample) | 1963-02-15 | |||
| BE754242A (fr) | 1970-07-15 | 1971-02-01 | Geigy Ag J R | Diamino-s-triazines et dinitro-s-triazines |
| US3867383A (en) | 1971-03-29 | 1975-02-18 | Ciba Geigy Corp | Monoanthranilatoanilino-s-triazines |
| BE793501A (fr) | 1971-12-31 | 1973-06-29 | Ciba Geigy | Composes heterocycliques et produits phytopharmaceutiques qui en contiennent |
| CH606334A5 (enExample) | 1974-06-21 | 1978-10-31 | Ciba Geigy Ag | |
| DE2928485A1 (de) | 1979-07-14 | 1981-01-29 | Bayer Ag | Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen |
| JPS58186682A (ja) | 1982-04-27 | 1983-10-31 | 日本化薬株式会社 | セルロ−ス又はセルロ−ス含有繊維材料の染色法 |
| DE3512630A1 (de) | 1985-04-06 | 1986-10-23 | Hoechst Ag, 6230 Frankfurt | Verfahren zum faerben oder bedrucken von cellulosefasern oder cellulosemischfasern |
| US5041443A (en) | 1989-02-21 | 1991-08-20 | Dainippon Pharmaceutical Co., Ltd. | Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof |
| DK0385237T3 (da) | 1989-03-03 | 1994-07-25 | Dainippon Pharmaceutical Co | 2-(1-Piperazinyl)-4-phenylcycloalkanopyridinderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende dem |
| JPH0491034A (ja) | 1990-08-02 | 1992-03-24 | Fujimoto Daiagunosuteitsukusu:Kk | 中枢神経保護剤 |
| JPH0499768A (ja) | 1990-08-17 | 1992-03-31 | Dainippon Pharmaceut Co Ltd | ４―（４―フェニルピリジン―２―イル）ピペラジン―１―オキシド誘導体 |
| JPH05140126A (ja) | 1991-11-26 | 1993-06-08 | Hokko Chem Ind Co Ltd | トリアゾール誘導体および除草剤 |
| CA2131004A1 (en) | 1992-02-28 | 1993-09-02 | Hideshi Kobayashi | S-triazine derivative and remedy for estrogen-dependent disease containing said derivative as effective component |
| IL115420A0 (en) | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
| IL117580A0 (en) | 1995-03-29 | 1996-07-23 | Merck & Co Inc | Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them |
| FR2735127B1 (fr) | 1995-06-09 | 1997-08-22 | Pf Medicament | Nouvelles piperazines heteroaromatiques utiles comme medicaments. |
| ES2100129B1 (es) | 1995-10-11 | 1998-02-16 | Medichem Sa | Nuevos compuestos aminopiridinicos policiclicos inhibidores de acetilcolinesterasa, procedimiento para su preparacion y su utilizacion. |
| GB9602166D0 (en) | 1996-02-02 | 1996-04-03 | Zeneca Ltd | Aminoheterocyclic derivatives |
| US6313127B1 (en) | 1996-02-02 | 2001-11-06 | Zeneca Limited | Heterocyclic compounds useful as pharmaceutical agents |
| US5807876A (en) | 1996-04-23 | 1998-09-15 | Vertex Pharmaceuticals Incorporated | Inhibitors of IMPDH enzyme |
| JPH09291034A (ja) | 1996-02-27 | 1997-11-11 | Yoshitomi Pharmaceut Ind Ltd | 縮合ピリジン化合物およびその医薬としての用途 |
| US6262113B1 (en) | 1996-03-20 | 2001-07-17 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| AU722662B2 (en) | 1996-05-20 | 2000-08-10 | Darwin Discovery Limited | Quinoline sulfonamides as TNF inhibitors and as PDE-IV inhibitors |
| US5984882A (en) | 1996-08-19 | 1999-11-16 | Angiosonics Inc. | Methods for prevention and treatment of cancer and other proliferative diseases with ultrasonic energy |
| CA2271744A1 (en) | 1996-11-14 | 1998-05-22 | Isao Hashiba | Cyanoethylmelamine derivatives and process for producing the same |
| US6399358B1 (en) | 1997-03-31 | 2002-06-04 | Thomas Jefferson University | Human gene encoding human chondroitin 6-sulfotransferase |
| JPH11158073A (ja) | 1997-09-26 | 1999-06-15 | Takeda Chem Ind Ltd | アデノシンａ３拮抗剤 |
| WO1999032463A1 (en) | 1997-12-22 | 1999-07-01 | Bayer Corporation | INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS |
| US7517880B2 (en) | 1997-12-22 | 2009-04-14 | Bayer Pharmaceuticals Corporation | Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| WO2000002864A1 (en) | 1998-07-10 | 2000-01-20 | Martens Juergen | Precusors for pna-monomers |
| US6783965B1 (en) | 2000-02-10 | 2004-08-31 | Mountain View Pharmaceuticals, Inc. | Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| ATE498409T1 (de) | 1998-08-06 | 2011-03-15 | Mountain View Pharmaceuticals | Peg-uricase konjugate und verwendung davon |
| UY25842A1 (es) | 1998-12-16 | 2001-04-30 | Smithkline Beecham Corp | Antagonistas de receptores de il-8 |
| AU5379900A (en) | 1999-06-07 | 2000-12-28 | Shire Biochem Inc. | Thiophene integrin inhibitors |
| WO2001016097A1 (en) | 1999-08-27 | 2001-03-08 | Sugen, Inc. | Phosphate mimics and methods of treatment using phosphatase inhibitors |
| ES2316383T3 (es) | 1999-09-17 | 2009-04-16 | Millennium Pharmaceuticals, Inc. | Benzamidas e inhibidores relacionados del factor xa. |
| CZ2002959A3 (cs) | 1999-09-17 | 2002-07-17 | Millennium Pharmaceuticals, Inc. | Inhibitory faktoru Xa |
| EP1246823A1 (en) | 1999-12-28 | 2002-10-09 | Pharmacopeia, Inc. | Pyrimidine and triazine kinase inhibitors |
| WO2001064642A2 (en) | 2000-02-29 | 2001-09-07 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
| EP1301484A2 (en) | 2000-07-20 | 2003-04-16 | Neurogen Corporation | Capsaicin receptor ligands |
| JP4113323B2 (ja) | 2000-08-07 | 2008-07-09 | 富士フイルム株式会社 | アゾ色素及びそれを含むインクジェット記録用インク、並びにインクジェット記録方法 |
| US6525091B2 (en) | 2001-03-07 | 2003-02-25 | Telik, Inc. | Substituted diarylureas as stimulators for Fas-mediated apoptosis |
| EP1389194A2 (en) | 2001-04-27 | 2004-02-18 | Vertex Pharmaceuticals Incorporated | Inhibitors of bace |
| CN1800185A (zh) | 2001-06-11 | 2006-07-12 | 比奥维特罗姆股份公司 | 取代的磺酰胺化合物、其制备方法及其作为治疗cns疾病、肥胖和ii型糖尿病的药物的应用 |
| CA2450934A1 (en) | 2001-06-19 | 2002-12-27 | Marco Dodier | Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| DE60238066D1 (de) | 2001-08-17 | 2010-12-02 | Basf Se | Triazinderivate und deren verwendung als sonnenschutzmittel |
| JP4753336B2 (ja) | 2001-09-04 | 2011-08-24 | 日本化薬株式会社 | 新規アリル化合物及びその製法 |
| US6878196B2 (en) | 2002-01-15 | 2005-04-12 | Fuji Photo Film Co., Ltd. | Ink, ink jet recording method and azo compound |
| US20040067234A1 (en) | 2002-07-11 | 2004-04-08 | Paz Einat | Isocitrate dehydrogenase and uses thereof |
| EP2256108B1 (en) | 2002-07-18 | 2016-03-23 | Janssen Pharmaceutica NV | Substituted triazine kinase inhibitors |
| JP2004083610A (ja) | 2002-08-22 | 2004-03-18 | Fuji Photo Film Co Ltd | インクセット、インクカートリッジ、記録方法、プリンター及び記録物 |
| JP2004107220A (ja) | 2002-09-13 | 2004-04-08 | Mitsubishi Pharma Corp | ＴＮＦ−α産生抑制剤 |
| TWI335913B (en) | 2002-11-15 | 2011-01-11 | Vertex Pharma | Diaminotriazoles useful as inhibitors of protein kinases |
| WO2004050033A2 (en) | 2002-12-02 | 2004-06-17 | Arqule, Inc. | Method of treating cancers |
| NZ541050A (en) | 2002-12-16 | 2010-06-25 | Genmab As | Human monoclonal antibodies against interleukin 8 (IL-8) |
| WO2004062604A2 (en) | 2003-01-10 | 2004-07-29 | Threshold Pharmaceuticals, Inc. | Treatment of cancer with 2-deoxyglucose |
| US7358262B2 (en) | 2003-01-29 | 2008-04-15 | Whitehead Institute For Biomedical Research | Identification of genotype-selective anti-tumor agents |
| WO2004074438A2 (en) | 2003-02-14 | 2004-09-02 | Smithkline Beecham Corporation | Ccr8 antagonists |
| WO2004073619A2 (en) | 2003-02-14 | 2004-09-02 | Smithkline Beecham Corporation | Ccr8 antagonists |
| ATE482747T1 (de) | 2003-04-11 | 2010-10-15 | High Point Pharmaceuticals Llc | Neue amide derivate und deren pharmazeutische verwendungen |
| WO2005013982A1 (en) | 2003-08-06 | 2005-02-17 | Vertex Pharmaceuticals Incorporated | Aminotriazole compounds useful as inhibitors of protein kinases |
| WO2005035507A2 (en) | 2003-10-10 | 2005-04-21 | Bayer Pharmaceuticals Corporation | 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders |
| JP4099768B2 (ja) | 2003-11-10 | 2008-06-11 | 富士電機デバイステクノロジー株式会社 | 電子写真感光体および該電子写真感光体に起因する干渉縞有無の判定方法 |
| US20070196395A1 (en) | 2003-12-12 | 2007-08-23 | Mackerell Alexander | Immunomodulatory compounds that target and inhibit the py'binding site of tyrosene kinase p56 lck sh2 domain |
| MXPA06008157A (es) | 2003-12-24 | 2007-09-07 | Johnson & Johnson | Tratamiento de gliomas malignos con inhibidores de factor de crecimiento transformante-beta. |
| JP2005264016A (ja) | 2004-03-19 | 2005-09-29 | Fuji Photo Film Co Ltd | インクジェット記録用インク、インクセット及びインクジェット記録方法 |
| US7335770B2 (en) | 2004-03-24 | 2008-02-26 | Reddy U5 Therapeutics, Inc. | Triazine compounds and their analogs, compositions, and methods |
| GB0412526D0 (en) | 2004-06-05 | 2004-07-14 | Leuven K U Res & Dev | Type 2 diabetes |
| BRPI0515500A (pt) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados piridazina para inibição de estearoil-coa-desaturase |
| CA2581454A1 (en) | 2004-09-23 | 2006-03-30 | Reddy Us Therapeutics, Inc. | Novel pyrimidine compounds, process for their preparation and compositions containing them |
| WO2006038594A1 (ja) | 2004-10-04 | 2006-04-13 | Ono Pharmaceutical Co., Ltd. | Ｎ型カルシウムチャネル阻害薬 |
| WO2006070198A1 (en) | 2004-12-30 | 2006-07-06 | Astex Therapeutics Limited | Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases |
| CN101146789A (zh) | 2005-01-25 | 2008-03-19 | 阿斯利康(瑞典)有限公司 | 化合物 |
| MX2007012548A (es) | 2005-04-11 | 2008-03-11 | Savient Pharmaceuticals Inc | Formas variantes de urato oxidasa y uso de las mismas. |
| ES2624863T3 (es) | 2005-06-08 | 2017-07-17 | Millennium Pharmaceuticals, Inc. | Métodos para identificación, evaluación, y tratamiento de pacientes con terapia de cáncer |
| GB0513702D0 (en) | 2005-07-04 | 2005-08-10 | Sterix Ltd | Compound |
| US8071597B2 (en) | 2005-08-26 | 2011-12-06 | Merck Serono Sa | Pyrazine compounds and uses as PI3K inhibitors |
| US8133900B2 (en) | 2005-11-01 | 2012-03-13 | Targegen, Inc. | Use of bi-aryl meta-pyrimidine inhibitors of kinases |
| TW200815426A (en) | 2006-06-28 | 2008-04-01 | Astrazeneca Ab | New pyridine analogues II 333 |
| US8343548B2 (en) | 2006-08-08 | 2013-01-01 | Shin-Etsu Chemical Co., Ltd. | Solid dosage form comprising solid dispersion |
| US20100297673A1 (en) | 2006-09-20 | 2010-11-25 | Reddy Us Therapeutics | Methods and compositions for upregulation of peroxiredoxin activity |
| US20080109846A1 (en) | 2006-10-23 | 2008-05-08 | Ewertz C Christian | System and method for audiovisual content playback |
| US7906555B2 (en) | 2006-10-26 | 2011-03-15 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance |
| HUP0600810A3 (en) | 2006-10-27 | 2008-09-29 | Richter Gedeon Nyrt | New sulfonamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them |
| PE20081229A1 (es) | 2006-12-01 | 2008-08-28 | Merck & Co Inc | Antagonistas de receptor de orexina de diazepam sustituido |
| JP2010511727A (ja) | 2006-12-04 | 2010-04-15 | ニューロクライン バイオサイエンシーズ，インコーポレイテッド | アデノシン受容体アンタゴニストとしての置換ピリミジン |
| KR101472765B1 (ko) | 2006-12-08 | 2014-12-15 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | 경구용 Ｘａ 인자 억제제를 포함하는 단위 용량 제형 및 경구용 Ｘａ 인자 억제제를 사용하는 혈전증의 치료 방법 |
| WO2008076883A2 (en) | 2006-12-15 | 2008-06-26 | Abraxis Bioscience, Inc. | Triazine derivatives and their therapeutical applications |
| JP5450381B2 (ja) | 2007-04-30 | 2014-03-26 | プロメティック・バイオサイエンスィズ・インコーポレーテッド | 化合物、そのような化合物を含有する組成物、及びそのような化合物を用いるがん及び自己免疫疾患の治療法 |
| EP2166849A4 (en) | 2007-06-11 | 2010-09-15 | Miikana Therapeutics Inc | SUBSTITUTED PYRAZOL COMPOUNDS |
| PT2176231T (pt) | 2007-07-20 | 2016-12-09 | Nerviano Medical Sciences Srl | Derivados de indazol substituídos activos como inibidores de quinases |
| US8415340B2 (en) | 2007-07-25 | 2013-04-09 | Bristol-Myers Squibb Company | Triazine kinase inhibitors |
| TW200906818A (en) | 2007-07-31 | 2009-02-16 | Astrazeneca Ab | Chemical compounds |
| WO2009048101A1 (ja) | 2007-10-10 | 2009-04-16 | Takeda Pharmaceutical Company Limited | アミド化合物 |
| WO2009051910A1 (en) * | 2007-10-16 | 2009-04-23 | The Regents Of The University Of California | Compounds having activity in increasing ion transport by mutant-cftr and uses thereof |
| WO2009086303A2 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| GB0805477D0 (en) | 2008-03-26 | 2008-04-30 | Univ Nottingham | Pyrimidines triazines and their use as pharmaceutical agents |
| JP5277685B2 (ja) | 2008-03-26 | 2013-08-28 | 富士ゼロックス株式会社 | 電子写真感光体、画像形成装置、プロセスカートリッジ及び画像形成方法 |
| US20090281089A1 (en) | 2008-04-11 | 2009-11-12 | Genentech, Inc. | Pyridyl inhibitors of hedgehog signalling |
| CN101575408B (zh) | 2008-05-09 | 2013-10-30 | Mca技术有限公司 | 用作阻燃剂和光稳定剂的聚三嗪基化合物 |
| PL3692983T3 (pl) | 2008-05-15 | 2021-12-27 | Celgene Corporation | Doustne formulacje analogów cytydyny i sposoby ich zastosowania |
| FR2932483A1 (fr) * | 2008-06-13 | 2009-12-18 | Cytomics Systems | Composes utiles pour le traitement des cancers. |
| WO2010007756A1 (ja) | 2008-07-14 | 2010-01-21 | 塩野義製薬株式会社 | Ｔｔｋ阻害作用を有するピリジン誘導体 |
| US8685660B2 (en) | 2008-09-03 | 2014-04-01 | The Johns Hopkins University | Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma |
| US20100144722A1 (en) | 2008-09-03 | 2010-06-10 | Dr. Reddy's Laboratories Ltd. | Novel heterocyclic compounds as gata modulators |
| JP2010079130A (ja) | 2008-09-29 | 2010-04-08 | Fuji Xerox Co Ltd | 電子写真感光体、プロセスカートリッジ、及び画像形成装置 |
| JP2012509321A (ja) | 2008-11-21 | 2012-04-19 | ミレニアム ファーマシューティカルズ， インコーポレイテッド | 癌および他の疾患または障害の処置のための、４−［６−メトキシ−７−（３−ピペリジン−１−イル−プロポキシ）キナゾリン−４−イル］ピペラジン−１−カルボン酸（４−イソプロポキシフェニル）−アミドの乳酸塩およびその薬学的組成物 |
| JP2010181540A (ja) | 2009-02-04 | 2010-08-19 | Fuji Xerox Co Ltd | 電子写真感光体、プロセスカートリッジ、及び画像形成装置 |
| US8673891B2 (en) | 2009-02-06 | 2014-03-18 | Nippon Shinyaku Co., Ltd. | Aminopyrazine derivative and medicine |
| US20120121515A1 (en) | 2009-03-13 | 2012-05-17 | Lenny Dang | Methods and compositions for cell-proliferation-related disorders |
| DK2427441T3 (en) | 2009-05-04 | 2017-03-20 | Agios Pharmaceuticals Inc | PKM2 Activators for use in the treatment of cancer |
| WO2010130638A1 (en) | 2009-05-14 | 2010-11-18 | Evotec Ag | Sulfonamide compounds, pharmaceutical compositions and uses thereof |
| WO2010144338A1 (en) | 2009-06-08 | 2010-12-16 | Abraxis Bioscience, Llc | Triazine derivatives and their therapeutical applications |
| WO2010144522A1 (en) | 2009-06-09 | 2010-12-16 | Abraxis Bioscience, Llc | Ureidophenyl substituted triazine derivatives and their therapeutical applications |
| JP2012529518A (ja) | 2009-06-09 | 2012-11-22 | アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー | ヘッジホッグシグナル伝達のピリジル−トリアジン阻害剤 |
| TWI598337B (zh) | 2009-06-29 | 2017-09-11 | 阿吉歐斯製藥公司 | 治療化合物及組成物 |
| ES2582535T3 (es) | 2009-07-10 | 2016-09-13 | Kirk Promotion Ltd. | Dispositivo de articulación de la rodilla |
| JP2013503846A (ja) | 2009-09-01 | 2013-02-04 | ファイザー・インク | ベンズイミダゾール誘導体 |
| WO2011032169A2 (en) | 2009-09-14 | 2011-03-17 | Phusis Therapeutics Inc. | Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same |
| JP5473851B2 (ja) | 2009-09-30 | 2014-04-16 | 富士フイルム株式会社 | 高分子フィルム、位相差フィルム、偏光板及び液晶表示装置 |
| US8652534B2 (en) | 2009-10-14 | 2014-02-18 | Berry Pharmaceuticals, LLC | Compositions and methods for treatment of mammalian skin |
| WO2011050210A1 (en) | 2009-10-21 | 2011-04-28 | Agios Pharmaceuticals, Inc. | Methods and compositions for cell-proliferation-related disorders |
| CN102574843B (zh) | 2009-10-22 | 2015-06-17 | 法博太科制药有限公司 | 抗纤维化剂的稠环类似物 |
| ES2642109T3 (es) | 2009-12-09 | 2017-11-15 | Agios Pharmaceuticals, Inc. | Compuestos terapéuticamente activos para su uso en el tratamiento de cáncer caracterizados por tener una mutación de IDH |
| NZ578968A (en) | 2010-02-10 | 2011-03-31 | Allans Sheetmetal And Engineering Services | Fuel feed system for a pellet fire |
| US20130197106A1 (en) | 2010-04-01 | 2013-08-01 | Agios Pharmaceuticals, Inc | Methods of identifying a candidate compound |
| WO2011143160A2 (en) | 2010-05-10 | 2011-11-17 | The Johns Hopkins University | Metabolic inhibitor against tumors having an idh mutation |
| US10064885B2 (en) | 2010-07-09 | 2018-09-04 | Massachusetts Institute Of Technology | Metabolic gene, enzyme, and flux targets for cancer therapy |
| CN103097340B (zh) | 2010-07-16 | 2018-03-16 | 安吉奥斯医药品有限公司 | 治疗活性组合物及其使用方法 |
| KR20190120458A (ko) | 2010-10-21 | 2019-10-23 | 메디베이션 테크놀로지즈 엘엘씨 | 결정질의 (8s,9r)-5-플루오로-8-(4-플루오로페닐)-9-(1-메틸-1h-1,2,4-트리아졸-5-일)-8,9-디하이드로-2h-피리도[4,3,2-de]프탈라진-3(7h)-온 토실레이트 염 |
| WO2012078288A2 (en) | 2010-11-08 | 2012-06-14 | Washington University | Methods of determining risk of adverse outcomes in acute myeloid leukemia |
| AU2011336764B2 (en) | 2010-11-29 | 2017-02-23 | Galleon Pharmaceuticals, Inc. | Novel compounds as respiratory stimulants for treatment of breathing control disorders or diseases |
| TWI549947B (zh) | 2010-12-29 | 2016-09-21 | 阿吉歐斯製藥公司 | 治療化合物及組成物 |
| WO2012173682A2 (en) | 2011-03-29 | 2012-12-20 | The Broad Institute, Inc. | Compounds and methods for the treatment of isocitrate dehydrognase related diseases |
| CN103608016A (zh) | 2011-05-03 | 2014-02-26 | 安吉奥斯医药品有限公司 | 丙酮酸激酶激活剂在治疗中的用途 |
| TWI555737B (zh) | 2011-05-24 | 2016-11-01 | 拜耳知識產權公司 | 含有硫醯亞胺基團之４－芳基－ｎ－苯基－１，３，５－三氮雜苯－２－胺 |
| JP2014522242A (ja) | 2011-06-06 | 2014-09-04 | メルク・シャープ・アンド・ドーム・コーポレーション | イソクエン酸デヒドロゲナーゼ（ｉｄｈ１）遺伝子発現のｒｎａ干渉媒介抑制 |
| CN102827170A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
| CN102827073A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
| CA2840883C (en) | 2011-07-07 | 2019-07-16 | Merck Patent Gmbh | Substituted azaheterocycles |
| EP3111937B1 (en) | 2011-07-08 | 2020-06-17 | Helmholtz-Zentrum für Infektionsforschung GmbH | Medicament for treatment of liver cancer |
| AU2012287103B2 (en) | 2011-07-22 | 2017-03-30 | University Of Louisville Research Foundation, Inc. | Anti-biofilm compounds |
| BR112014007310A2 (pt) | 2011-09-27 | 2017-04-04 | Novartis Ag | 3-pirimidin-4-il-oxazolidin-2-onas como inibidores de idh mutante |
| CN102659765B (zh) | 2011-12-31 | 2014-09-10 | 沈阳药科大学 | 嘧啶及三嗪类化合物的制备方法和应用 |
| PE20142098A1 (es) | 2012-01-06 | 2015-01-08 | Agios Pharmaceuticals Inc | Compuestos terapeuticamente activos y sus metodos de uso |
| US20150087600A1 (en) | 2012-01-19 | 2015-03-26 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
| US9474779B2 (en) | 2012-01-19 | 2016-10-25 | Agios Pharmaceuticals, Inc. | Therapeutically active compositions and their methods of use |
| EP2634259A1 (en) | 2012-03-01 | 2013-09-04 | Deutsches Krebsforschungszentrum | Means and methods for the determination of (D)-2-hydroxyglutarate (D2HG) |
| KR20140131955A (ko) | 2012-03-09 | 2014-11-14 | 카나 바이오사이언스 인코포레이션 | 신규 트리아진 유도체 |
| WO2014015422A1 (en) | 2012-07-27 | 2014-01-30 | Ontario Institute For Cancer Research | Cellulose-based nanoparticles for drug delivery |
| EP2906212A4 (en) | 2012-10-15 | 2016-06-08 | Agios Pharmaceuticals Inc | THERAPEUTIC COMPOUNDS AND COMPOSITIONS |
| WO2015003360A2 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| WO2015010297A1 (en) | 2013-07-25 | 2015-01-29 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| WO2015127173A1 (en) | 2014-02-20 | 2015-08-27 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
| NZ723859A (en) | 2014-03-14 | 2023-01-27 | Servier Lab | Pharmaceutical compositions of therapeutically active compounds and their uses |
| MA39725B1 (fr) | 2014-03-14 | 2021-09-30 | Les Laboratoires Servier Sas | Compositions pharmaceutiques de composés thérapeutiquement actifs |
| KR102699521B1 (ko) | 2015-10-15 | 2024-08-26 | 르 라보레또레 쎄르비에르 | 악성 종양의 치료를 위한 조합물 요법 |
| FI3362065T3 (fi) | 2015-10-15 | 2024-06-19 | Servier Lab | Ivosidenibiä, sytarabiinia ja daunorubisiinia tai idarubisiinia käsittävä yhdistelmähoito akuutin myelooisen leukemian hoitamiseksi |
| ES2905915T3 (es) | 2015-12-04 | 2022-04-12 | Servier Lab | Procedimientos de tratamiento de neoplasias malignas |
| MA43640A (fr) | 2016-02-26 | 2018-11-28 | Agios Pharmaceuticals Inc | Inhibiteurs de idh1 pour le traitement de cancers hématologiques et de tumeurs solides |
-
2013
- 2013-01-18 US US13/745,005 patent/US9474779B2/en active Active
- 2013-01-21 LT LTEP18183579.4T patent/LT3447052T/lt unknown
- 2013-01-21 SM SM20220027T patent/SMT202200027T1/it unknown
- 2013-01-21 SG SG10202103521PA patent/SG10202103521PA/en unknown
- 2013-01-21 ES ES13738319.6T patent/ES2685746T3/es active Active
- 2013-01-21 MY MYPI2014002104A patent/MY178486A/en unknown
- 2013-01-21 NZ NZ627053A patent/NZ627053A/en unknown
- 2013-01-21 EP EP21203128.0A patent/EP3985001B1/en active Active
- 2013-01-21 KR KR1020147022964A patent/KR102044730B1/ko active Active
- 2013-01-21 PE PE2019000472A patent/PE20190801A1/es not_active Application Discontinuation
- 2013-01-21 HR HRP20220017TT patent/HRP20220017T1/hr unknown
- 2013-01-21 MX MX2014008744A patent/MX351166B/es active IP Right Grant
- 2013-01-21 SI SI201331959T patent/SI3447052T1/sl unknown
- 2013-01-21 SM SM20180439T patent/SMT201800439T1/it unknown
- 2013-01-21 NZ NZ722400A patent/NZ722400A/en unknown
- 2013-01-21 RS RS20181025A patent/RS57730B1/sr unknown
- 2013-01-21 CA CA3077245A patent/CA3077245A1/en not_active Abandoned
- 2013-01-21 SI SI201331138T patent/SI2804851T1/sl unknown
- 2013-01-21 PT PT181835794T patent/PT3447052T/pt unknown
- 2013-01-21 PT PT13738319T patent/PT2804851T/pt unknown
- 2013-01-21 HU HUE18183579A patent/HUE057264T2/hu unknown
- 2013-01-21 PL PL18183579T patent/PL3447052T3/pl unknown
- 2013-01-21 EA EA201692271A patent/EA035662B1/ru unknown
- 2013-01-21 SG SG11201404190PA patent/SG11201404190PA/en unknown
- 2013-01-21 MY MYPI2017001804A patent/MY203015A/en unknown
- 2013-01-21 CR CR20170097A patent/CR20170097A/es unknown
- 2013-01-21 TW TW107116320A patent/TWI713847B/zh active
- 2013-01-21 ES ES18183579T patent/ES2903390T3/es active Active
- 2013-01-21 DK DK13738319.6T patent/DK2804851T3/en active
- 2013-01-21 DK DK18183579.4T patent/DK3447052T3/da active
- 2013-01-21 PE PE2014001128A patent/PE20141824A1/es active IP Right Grant
- 2013-01-21 AU AU2013211436A patent/AU2013211436B2/en active Active
- 2013-01-21 WO PCT/CN2013/000068 patent/WO2013107291A1/en not_active Ceased
- 2013-01-21 CN CN201380009364.XA patent/CN104136411B/zh active Active
- 2013-01-21 EA EA201491391A patent/EA026723B1/ru unknown
- 2013-01-21 CN CN201610805857.XA patent/CN106496090B/zh active Active
- 2013-01-21 EP EP13738319.6A patent/EP2804851B1/en active Active
- 2013-01-21 HU HUE13738319A patent/HUE039110T2/hu unknown
- 2013-01-21 UA UAA201409238A patent/UA115047C2/uk unknown
- 2013-01-21 IN IN5986DEN2014 patent/IN2014DN05986A/en unknown
- 2013-01-21 HR HRP20181199TT patent/HRP20181199T1/hr unknown
- 2013-01-21 BR BR112014017840-2A patent/BR112014017840B1/pt active IP Right Grant
- 2013-01-21 UA UAA201700262A patent/UA122324C2/uk unknown
- 2013-01-21 CA CA2861556A patent/CA2861556C/en active Active
- 2013-01-21 EP EP18183579.4A patent/EP3447052B1/en active Active
- 2013-01-21 SG SG10201608374XA patent/SG10201608374XA/en unknown
- 2013-01-21 AR ARP130100177A patent/AR089768A1/es active IP Right Grant
- 2013-01-21 JP JP2014552489A patent/JP6313714B2/ja active Active
- 2013-01-21 KR KR1020197033106A patent/KR102108507B1/ko active Active
- 2013-01-21 LT LTEP13738319.6T patent/LT2804851T/lt unknown
- 2013-01-21 PL PL13738319T patent/PL2804851T3/pl unknown
- 2013-01-21 RS RS20220030A patent/RS62919B1/sr unknown
- 2013-01-21 MX MX2017012624A patent/MX380943B/es unknown
- 2013-01-21 TW TW102102190A patent/TWI636040B/zh active
- 2013-01-21 KR KR1020207012665A patent/KR102144739B1/ko active Active
-
2014
- 2014-07-15 PH PH12014501626A patent/PH12014501626B1/en unknown
- 2014-07-17 IL IL233683A patent/IL233683B/en active IP Right Grant
- 2014-07-17 CL CL2014001891A patent/CL2014001891A1/es unknown
- 2014-07-18 NI NI201400078A patent/NI201400078A/es unknown
- 2014-07-18 CO CO14156115A patent/CO7010834A2/es unknown
- 2014-08-18 CR CR20140388A patent/CR20140388A/es unknown
- 2014-08-18 EC ECIEPI201414544A patent/ECSP14014544A/es unknown
-
2016
- 2016-01-05 US US14/988,661 patent/US20160130298A1/en not_active Abandoned
- 2016-09-28 US US15/279,146 patent/US9850277B2/en active Active
-
2017
- 2017-02-28 JP JP2017036691A patent/JP2017101067A/ja not_active Withdrawn
- 2017-08-08 PH PH12017501419A patent/PH12017501419B1/en unknown
- 2017-11-10 US US15/809,325 patent/US10640534B2/en active Active
- 2017-11-23 AU AU2017265100A patent/AU2017265100B2/en active Active
-
2018
- 2018-06-29 PH PH12018501410A patent/PH12018501410A1/en unknown
- 2018-09-04 CY CY181100915T patent/CY1120651T1/el unknown
- 2018-11-02 JP JP2018207185A patent/JP6805220B2/ja active Active
-
2019
- 2019-01-28 IL IL264516A patent/IL264516B/en active IP Right Grant
- 2019-05-31 US US16/427,691 patent/US10717764B2/en active Active
- 2019-12-19 AU AU2019283951A patent/AU2019283951B2/en active Active
-
2020
- 2020-06-05 US US16/893,750 patent/US11667673B2/en active Active
- 2020-11-30 JP JP2020198026A patent/JP2021038263A/ja not_active Withdrawn
-
2021
- 2021-01-19 ZA ZA2021/00373A patent/ZA202100373B/en unknown
- 2021-03-31 IL IL281942A patent/IL281942B/en unknown
- 2021-07-07 AR ARP210101907A patent/AR122902A2/es unknown
-
2022
- 2022-01-19 CY CY20221100045T patent/CY1124988T1/el unknown
-
2023
- 2023-02-17 US US18/111,511 patent/US20240059733A1/en active Pending
- 2023-09-07 FR FR23C1031C patent/FR23C1031I2/fr active Active
- 2023-09-17 LU LU00315C patent/LUC00315I2/en unknown
- 2023-09-18 NL NL301243C patent/NL301243I2/nl unknown
- 2023-10-10 LT LTPA2023529C patent/LTC2804851I2/lt unknown
- 2023-10-10 FI FIC20230031C patent/FIC20230031I1/fi unknown
- 2023-10-10 HU HUS2300035C patent/HUS2300035I1/hu unknown
- 2023-10-13 NO NO2023038C patent/NO2023038I1/no unknown
- 2023-10-27 CY CY2023023C patent/CY2023023I1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015509098A5 (enExample) | ||
| KR20210087440A (ko) | 삼중 음성 유방암의 치료를 위한 병용 요법 | |
| JP2013545823A5 (enExample) | ||
| JP2015511217A5 (enExample) | ||
| JP2016525130A5 (enExample) | ||
| JP2016517851A5 (enExample) | ||
| JP2018535967A5 (enExample) | ||
| JP2019517487A5 (enExample) | ||
| JP2016531126A5 (enExample) | ||
| JP2012520861A5 (enExample) | ||
| JP2016040288A5 (enExample) | ||
| JP2015520143A5 (enExample) | ||
| JP2016006118A5 (enExample) | ||
| JP2014500295A5 (enExample) | ||
| JP2014508811A5 (enExample) | ||
| JP2014015465A5 (enExample) | ||
| RU2015118647A (ru) | Аминопиримидиновые соединения в качестве ингибиторов содержащих т790м мутантных egfr | |
| JP2015508103A5 (enExample) | ||
| JP2016526540A5 (enExample) | ||
| JP2016512505A5 (enExample) | ||
| JP2013537203A5 (enExample) | ||
| RU2019131017A (ru) | Соединения гетероарила в качестве ингибиторов btk и их применение | |
| JP2013508288A5 (enExample) | ||
| WO2014145025A2 (en) | 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities | |
| JP2015501833A5 (enExample) |